Results 261 to 270 of about 63,084 (277)

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Lancet, The, 2018
Désirée M Van Der Heijde, James C-C Wei, Maxime Dougados   +2 more
exaly  

Axial spondyloarthritis: concept, construct, classification and implications for therapy

Nature Reviews Rheumatology, 2020
Philip C Robinson, Sjef M Van Der Linden, Muhammad A Khan   +2 more
exaly  

Spondyloarthritis

Rheumatology, 1997
openaire   +1 more source

Inhibition of interleukin-17 in axial spondyloarthritis spectrum

Lancet, The, 2020
exaly  

IBD and spondyloarthritis: joint management

Nature Reviews Gastroenterology and Hepatology, 2015
Paolo Gionchetti, Fernando Rizzello
exaly  

Referral strategies for early diagnosis of axial spondyloarthritis

Nature Reviews Rheumatology, 2012
Joachim Sieper
exaly  

Spondyloarthritis

2012
Lihi Eder, Dafna D. Gladman
openaire   +1 more source

Spondyloarthritis

2018
Heleen Cypers, S. Louis Bridges, Dirk Elewaut   +2 more
openaire   +1 more source

New evidence on the management of spondyloarthritis

Nature Reviews Rheumatology, 2016
Joachim Sieper, Denis Poddubnyy
exaly  

Spondyloarthritis

2008
openaire   +1 more source